Heart and lung transplantation in patients with end stage lung disease.
Combined heart and lung transplantation was used to treat seven patients with end stage lung disease. All were severely disabled, and their disease carried a poor prognosis. Six patients were well four to 33 months after transplantation. One patient died after 44 days from a primary cytomegalovirus pneumonia transmitted from the donor. All the survivors had normal exercise tolerance and greatly improved lung function. It is concluded that heart and lung transplantation is a suitable treatment for selected patients with end stage chronic lung disease.
D000328:Adult; D002908:Chronic Disease; D005260:Female; D005541:Forced Expiratory Volume; D006321:Heart / Q000503:physiopathology; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008171:Lung Diseases / Q000503:physiopathology / Q000601:surgery*; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis